OverviewChartNewsTraderScreen

Evoke Pharma/  US30049G2030  /

IEX
6/14/2024  9:59:50 PM Chg. -0.06 Volume Bid- Ask- High Low
0.50USD -10.31% 345
Turnover: 161.03		 -Bid Size: - -Ask Size: - 0.51 0.45
GlobeNewswire 5/16 Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care ...
GlobeNewswire 5/14 Evoke Pharma Reports First Quarter 2024 Financial Results
GlobeNewswire 4/17 Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastropar...
GlobeNewswire 3/21 Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief ...
GlobeNewswire 3/14 Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 3/7 Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024
GlobeNewswire 2/14 Evoke Pharma Announces Closing of $7.5 Million Public Offering
GlobeNewswire 2/9 Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
GlobeNewswire 11/27/2023 Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI Patent
GlobeNewswire 11/14/2023 United States Patent and Trademark Office (USPTO) Grants Another Formulation Patent Covering GIMOTI
GlobeNewswire 11/9/2023 Evoke Pharma Reports Third Quarter 2023 Financial Results
GlobeNewswire 10/31/2023 Evoke Pharma & EVERSANA Unveil Cost Savings Real-World Data Demonstrating Meaningfully Reduced Healt...
GlobeNewswire 10/18/2023 Evoke Pharma’s Abstract Entitled “Superiority of Nasal Spray Compared to Orally Administered Metoclo...
GlobeNewswire 3/10/2022 Evoke Pharma Announces Key Opinion Leader Fireside Chat to Discuss Gastroparesis Treatment Landscape
GlobeNewswire 3/8/2022 Evoke Pharma Reports Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire 3/1/2022 Evoke Pharma to Report Fourth Quarter and Full Year 2021 Financial Results on March 8, 2022
GlobeNewswire 2/17/2022 GIMOTI® Commercialization Update
GlobeNewswire 2/2/2022 Evoke Pharma and EVERSANA Extend Commercialization Partnership to Further Support GIMOTI
GlobeNewswire 1/4/2022 Evoke Pharma to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference
GlobeNewswire 11/10/2021 Evoke Pharma Reports Third Quarter 2021 Financial Results
GlobeNewswire 11/3/2021 Evoke Pharma to Report Third Quarter 2021 Financial Results on November 10, 2021
GlobeNewswire 10/20/2021 Evoke Pharma and EVERSANA Announce Positive Findings from GIMOTI® Market Research Study
GlobeNewswire 9/29/2021 Evoke Pharma’s Commercial Partner EVERSANA, Receives PM360’s Trailblazer Initiative Award for Innova...
GlobeNewswire 9/1/2021 Evoke Pharma to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
GlobeNewswire 8/12/2021 Evoke Pharma Reports Second Quarter 2021 Financial Results